Your browser doesn't support javascript.
loading
A novel small compound TOIDC suppresses lipogenesis via SREBP1-dependent signaling to curb MAFLD.
Shao, Yaodi; Yao, Zhi; Zhou, Junyi; Yu, Miao; Chen, Suzhen; Yuan, Yanmei; Han, Liu; Jiang, Liqin; Liu, Junli.
Affiliation
  • Shao Y; Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Diabetes Institute, Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China.
  • Yao Z; School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, 200241, China.
  • Zhou J; School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, 200241, China.
  • Yu M; School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, 200241, China.
  • Chen S; Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Diabetes Institute, Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China.
  • Yuan Y; Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Diabetes Institute, Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China.
  • Han L; Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Diabetes Institute, Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China. hanliu1192956838@163.com.
  • Jiang L; School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, 200241, China. jiangliqin_777@163.com.
  • Liu J; Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Diabetes Institute, Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China. liujunli@sjtu.edu.cn.
Nutr Metab (Lond) ; 19(1): 80, 2022 Dec 06.
Article de En | MEDLINE | ID: mdl-36474251

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies Langue: En Journal: Nutr Metab (Lond) Année: 2022 Type de document: Article Pays d'affiliation: Chine

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies Langue: En Journal: Nutr Metab (Lond) Année: 2022 Type de document: Article Pays d'affiliation: Chine